ORION Clinical Services   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Slough United Kingdom (1997)
Status: Acquired by Simbec-Orion (2014)

Organization Overview

First Clinical Trial
2004
NCT00083941
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ORION Clinical Services

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Glioblastoma (Phase 1)

Hyperalgesia (Phase 1)

Pancreatic Neoplasms (Phase 3)

Pneumococcal Infections (Phase 1)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 12